Kincell Bio
United States
- Durham, NC
- 16/05/2025
- Unknown
- $22,000,000
Kincell Bio partners with innovators to advance autologous and allogeneic cell therapies for patients in need of therapeutic solutions. With manufacturing facilities located in Research Triangle Park, NC, and Gainesville, FL, Kincell Bio is a Cell therapy CDMO with the mission to streamline CMC development, apply expertise in analytical and process development, and facilitate quality-first, reliable GMP supply from early clinical to pivotal studies and product launch.
Kincell Bio’s platform offers clients a personalized, responsive, and expert-driven approach to process development and manufacturing from early clinical to pivotal supply and commercial launch, ensuring rapid timelines without compromising on quality.
- Industry Pharmaceutical Manufacturing
- Website https://kincellbio.com/
- LinkedIn https://www.linkedin.com/company/kincellbio/
Ciphero | $2,500,000 | (Dec 23, 2025)
beycome | $2,500,000 | (Dec 23, 2025)
Givefront | $2,000,000 | (Dec 23, 2025)
StretchSense | $2,300,000 | (Dec 23, 2025)
ZeroPhase | $6,800,000 | (Dec 23, 2025)
Peripheral Labs | $3,600,000 | (Dec 23, 2025)
Ethereal Exploration Guild | $21,000,000 | (Dec 23, 2025)
LatentForce | $1,700,000 | (Dec 23, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Amphix Bio | $12,500,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)